Literature DB >> 29122111

Temperature-sensitive Medications in Interfacility Transport: The Ice Pack Myth.

Jason Clancy1, Cassandra Karish2, Meghan Roddy2, Judith J Sicilia3, Michael T Bigham4.   

Abstract

INTRODUCTION: Critical Care Transport teams use various strategies to maintain temperature sensitive drugs and equipment at optimal temperature. The purpose of this study was to examine the effectiveness of current passive refrigeration of temperature sensitive transport medications/equipment.
METHODS: Initially, we performed a retrospective review of transport durations. Subsequently, an experimental paradigm was created using a temperature probe inside of the transport cooler packs utilizing various configurations and initial starting temperatures with high and low "in range" temperature margins of 8°C (max) and 2°C (min).
RESULTS: The mean round-trip transport time was 2.5 hours and over 15% of transports last longer than 4 hours. At a starting temperature of -3.9°C, the cooler and ice pack maintained "in range" temperatures for 3 hours. When the ice pack starting temperature was -12.9°C, high temperatures excursions weren't experienced until 6 hours 55 minutes, but initially low excursions fell below for up to 3 hours. iSTAT® cartridges remained within range between 1-4 hours at cooler and ice pack starting temperature of -3.9°C.
CONCLUSION: The current system of passive refrigeration does not appear to be sufficient for safely storing medications or point-of-care testing equipment for our transport services. This might reveal a flaw in the existing practices around medication refrigeration in transport.
Copyright © 2017 Air Medical Journal Associates. Published by Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2017        PMID: 29122111     DOI: 10.1016/j.amj.2017.05.002

Source DB:  PubMed          Journal:  Air Med J        ISSN: 1067-991X


  2 in total

1.  Analysis and modeling of coolants and coolers for specimen transportation.

Authors:  David E Lowe; Gerald Pellegrini; Elizabeth LeMasters; Andrew J Carter; Zachary P Weiner
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

2.  Mean kinetic temperature evaluations through simulated temperature excursions and risk assessment with oral dosage usage for health programs.

Authors:  David Jenkins; Aida Cancel; Thomas Layloff
Journal:  BMC Public Health       Date:  2022-02-14       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.